A study by Australian researchers compared three mRNA-LNP vaccine platforms in human blood samples, generating findings that ...

Moderna was recently added to the Nasdaq-100 Index after positive Phase 3 data for its personalized cancer vaccine with Merck ...

LONDON, Oct. 16 (Xinhua) -- British researchers are bringing artificial intelligence (AI), automated laboratories and supercomputing together to accelerate the development of personalized cancer ...

- Moderna's stock fell nearly 10% as its cancer vaccine's valuation outpaces analyst targets by ~$35B. - The personalized ...

PharmaJet to highlight vaccine development opportunities and real-world impact with needle-free delivery at World Vaccine Congress Europe: Golden, Colorado Saturday, October 17, 2 ...

SELLAS Life Sciences Group Inc. stocks have been trading down by -12.57 percent amid bearish sentiment on biotech sector ...

Arcadia's Michael Meucci sat down for an exclusive interview with Newsweek.

Immunosenescence makes adults 65 and over vulnerable to flu, and high-immunogenicity vaccines may help offset weakened ...

A comprehensive Molecular Cancer review explains how antibody-drug conjugates deliver lethal payloads to tumors, why ...

A study of nearly 32,000 women in Shaanxi, China, found an overall HPV prevalence of 21.46 percent and showed that women ...

The decision from Brussels could have implications for the canton of Zurich. “We will notice the increasing hunting pressure ...

A new $55 million medical facility has opened in South Carolina, featuring an outdoor healing garden. This garden was funded ...